Chemicals & Advanced Materials Global On demand · 24-48h

Global Electrophoresis Buffer Reagents Market Strategic Research Report

Global Electrophoresis Buffer Reagents Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Electrophoresis Buffer Reagents Market
$1.38B2025
6.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Tris-Acetate-EDTA (TAE) Buffer (Value & Volume), Tris-Borate-EDTA (TBE) Buffer (Value & Volume), Sodium Borate (SB) & Lithium Borate (LB) Buffers (Value & Volume), MOPS and HEPES-Based Buffers (Value & Volume), Laemmli SDS-PAGE Running Buffers (Value & Volume), Capillary Electrophoresis Electrolyte Buffers (Value & Volume)

By Application: Nucleic Acid Gel Electrophoresis (DNA/RNA Separation) (Value & Volume), Protein Gel Electrophoresis (SDS-PAGE & Native PAGE) (Value & Volume), Western Blotting & Immunoblotting (Value & Volume), Capillary Electrophoresis for Biopharmaceutical QC (Value & Volume), Clinical Diagnostics & Serum Protein Electrophoresis (Value & Volume)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA (MilliporeSigma), Agilent Technologies, Lonza Group, Cytiva (Danaher), Promega Corporation, New England Biolabs, Serva Electrophoresis GmbH, National Diagnostics

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Market size 2025
$1.38B
Billion USD
Forecast CAGR
6.6%
2025-2032
Forecast 2032
$2.2B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

The global electrophoresis buffer reagents market occupies a foundational position within the life sciences tools and reagents ecosystem, providing the chemically precise ionic environments essential for the separation, identification, and quantification of nucleic acids and proteins across research, clinical diagnostics, and biopharmaceutical manufacturing workflows. Valued at approximately USD 1.38 billion in 2024, the market has matured from a commodity consumables segment into a technically differentiated space where buffer formulation chemistry, reproducibility, and regulatory compliance command significant pricing power. The proliferation of genomics, proteomics, and next-generation sequencing workflows across academic, government, and industrial laboratories has embedded electrophoresis buffer reagents as a recurring, high-frequency purchase across an expanding global installed base of electrophoresis systems.

Three principal forces are shaping demand trajectories through 2032. First, the accelerating global investment in genomics infrastructure — particularly multi-year national sequencing programs in the United States, China, and the United Kingdom — is sustaining high-volume consumption of Tris-acetate-EDTA, Tris-borate-EDTA, and MOPS-based buffers used in agarose and polyacrylamide gel electrophoresis. Second, the rapid scale-up of biopharmaceutical manufacturing and biosimilar development has intensified demand for high-purity, cGMP-grade buffer reagents used in capillary electrophoresis quality-control testing, where batch-to-batch consistency is non-negotiable for regulatory submissions to the FDA and EMA. Third, the expansion of point-of-care molecular diagnostics — accelerated by pandemic-era infrastructure investment — is broadening addressable demand beyond traditional academic and central-laboratory settings. The principal restraint is the persistent price sensitivity among academic and small-laboratory end-users, which limits premium product adoption and exerts downward pressure on average selling prices in markets where local, lower-specification suppliers compete aggressively.

This report delivers a comprehensive quantitative and qualitative analysis of the global electrophoresis buffer reagents market across the 2025–2032 forecast period, covering segmentation by buffer type, application, and end-use sector, with granular regional breakdowns spanning Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. Country-level forecasts are provided for the United States, China, Germany, Japan, India, and the United Kingdom. The report profiles ten leading market participants and examines the competitive, regulatory, and technological forces reshaping the industry. Corporate strategy teams evaluating portfolio expansion, investment analysts assessing specialty reagents sub-sectors, M&A advisors conducting target screening, and procurement managers benchmarking supplier options will find this analysis directly actionable.

Market snapshot

Global Electrophoresis Buffer Reagents Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.38B
2025
Forecast
$2.2B
2032
Volume
42
Thousand Metric Tonnes, 2025
Volume 2032
65.7
Thousand Metric Tonnes
Key companies
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)Agilent TechnologiesLonza GroupCytiva (Danaher)Promega CorporationNew England Biolabs
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Tris-Acetate-EDTA (TAE) Buffer (Value & Volume)Tris-Borate-EDTA (TBE) Buffer (Value & Volume)Sodium Borate (SB) & Lithium Borate (LB) Buffers (Value & Volume)MOPS and HEPES-Based Buffers (Value & Volume)Laemmli SDS-PAGE Running Buffers (Value & Volume)Capillary Electrophoresis Electrolyte Buffers (Value & Volume)
By Application
Nucleic Acid Gel Electrophoresis (DNA/RNA Separation) (Value & Volume)Protein Gel Electrophoresis (SDS-PAGE & Native PAGE) (Value & Volume)Western Blotting & Immunoblotting (Value & Volume)Capillary Electrophoresis for Biopharmaceutical QC (Value & Volume)Clinical Diagnostics & Serum Protein Electrophoresis (Value & Volume)

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value & Volume Forecast (Thousand Metric Tonnes), 2025-2032
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
  • 3.1 Market by Type Overview
  • 3.2 Tris-Acetate-EDTA (TAE) Buffer (Value & Volume)
  • 3.3 Tris-Borate-EDTA (TBE) Buffer (Value & Volume)
  • 3.4 Sodium Borate (SB) & Lithium Borate (LB) Buffers (Value & Volume)
  • 3.5 MOPS and HEPES-Based Buffers (Value & Volume)
  • 3.6 Laemmli SDS-PAGE Running Buffers (Value & Volume)
  • 3.7 Capillary Electrophoresis Electrolyte Buffers (Value & Volume)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Nucleic Acid Gel Electrophoresis (DNA/RNA Separation) (Value & Volume)
  • 4.3 Protein Gel Electrophoresis (SDS-PAGE & Native PAGE) (Value & Volume)
  • 4.4 Western Blotting & Immunoblotting (Value & Volume)
  • 4.5 Capillary Electrophoresis for Biopharmaceutical QC (Value & Volume)
  • 4.6 Clinical Diagnostics & Serum Protein Electrophoresis (Value & Volume)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 Asia Pacific (Value & Volume)
  • 5.3 North America (Value & Volume)
  • 5.4 Europe (Value & Volume)
  • 5.5 Middle East & Africa
  • 5.6 Latin America
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 China
  • 6.4 Germany
  • 6.5 Japan
  • 6.6 India
  • 6.7 United Kingdom
07Growth Drivers & Inhibitors
  • 7.1 Expansion of National Genomics and Whole-Genome Sequencing Programs Driving Consumable Demand
  • 7.2 Biopharmaceutical Manufacturing Scale-Up and Biosimilar Development Increasing cGMP-Grade Buffer Consumption
  • 7.3 Growth of Point-of-Care and Decentralized Molecular Diagnostics Broadening Addressable End-Markets
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific — Revenue, Strategy, Key Products
  • 8.2 Bio-Rad Laboratories — Revenue, Strategy, Key Products
  • 8.3 Merck KGaA (MilliporeSigma) — Revenue, Strategy, Key Products
  • 8.4 Agilent Technologies — Revenue, Strategy, Key Products
  • 8.5 Lonza Group — Revenue, Strategy, Key Products
  • 8.6 Cytiva (Danaher) — Revenue, Strategy, Key Products
  • 8.7 Promega Corporation — Revenue, Strategy, Key Products
  • 8.8 New England Biolabs (NEB) — Revenue, Strategy, Key Products
  • 8.9 Serva Electrophoresis GmbH — Revenue, Strategy, Key Products
  • 8.10 National Diagnostics — Revenue, Strategy, Key Products
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 Adoption of Low-Toxicity, Borate-Free Buffer Formulations in Response to Laboratory Safety Regulations
  • 13.2 Proliferation of Ready-to-Use Premixed and Stabilized Buffer Formats Displacing Powder-Form Reagents
  • 13.3 Integration of Electrophoresis Buffer Kits with Automated High-Throughput Liquid-Handling Platforms
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the electrophoresis buffer reagents market?
The global electrophoresis buffer reagents market was valued at approximately USD 1.38 billion in 2024 and is projected to reach approximately USD 2.31 billion by 2032, reflecting steady growth driven by expanding genomics research, biopharmaceutical manufacturing, and clinical diagnostics applications. In volume terms, global consumption stood at roughly 42 thousand metric tonnes in 2024.
What is the CAGR of the electrophoresis buffer reagents market?
The global electrophoresis buffer reagents market is forecast to grow at a compound annual growth rate of approximately 6.6% over the 2025–2032 forecast period, with Asia Pacific expected to record the fastest regional CAGR, exceeding 8.2%, driven by China's and India's expanding life sciences research infrastructure.
What is driving growth in the electrophoresis buffer reagents market?
Three specific drivers are propelling market expansion. National whole-genome sequencing programs in the United States, China, and the United Kingdom are sustaining high recurring consumption of TAE and TBE buffers. The global biopharmaceutical manufacturing build-out — particularly for mRNA therapeutics and monoclonal antibody biosimilars — is increasing demand for cGMP-grade capillary electrophoresis buffers used in regulatory-compliant quality-control testing. Additionally, the post-pandemic expansion of decentralized and point-of-care molecular diagnostics infrastructure is widening the addressable market beyond traditional academic and central-laboratory settings.
Who are the leading companies in the electrophoresis buffer reagents market?
The market is led by Thermo Fisher Scientific, which commands the largest share through its broad portfolio of pre-cast gel systems and matched buffer reagents. Bio-Rad Laboratories holds a strong position in protein electrophoresis buffer systems, while Merck KGaA (MilliporeSigma) serves both research and biopharmaceutical-grade segments. Cytiva (a Danaher company) and Lonza Group are prominent in life science manufacturing applications, and Agilent Technologies leads in capillary electrophoresis electrolyte buffers for pharmaceutical QC workflows.
Which region dominates the electrophoresis buffer reagents market?
North America held the largest regional revenue share in 2024, accounting for approximately 38% of global market value, underpinned by the concentration of leading biopharmaceutical companies, NIH-funded academic research institutions, and a well-developed clinical diagnostics infrastructure in the United States. Asia Pacific is the fastest-growing region and is expected to narrow the gap considerably by 2032 as China, India, and South Korea continue scaling their life sciences research investments.
What segments are covered in this report?
The report covers segmentation by buffer type — including TAE, TBE, sodium and lithium borate buffers, MOPS and HEPES-based buffers, Laemmli SDS-PAGE running buffers, and capillary electrophoresis electrolyte buffers — as well as by application, spanning nucleic acid gel electrophoresis, protein gel electrophoresis (SDS-PAGE and native PAGE), western blotting, capillary electrophoresis for biopharmaceutical QC, and clinical serum protein electrophoresis. Regional and country-level segmentation is also provided.
What is the forecast period covered in this report?
This report covers a forecast period of 2025 to 2032, with 2024 serving as the base year. Historical data is provided from 2019 to 2024 to contextualise growth trajectories and enable trend analysis across both pre- and post-pandemic market conditions.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.